https://www.selleckchem.com/products/dihexa.html
0 vs 68.9 years) and had less comorbidities. After propensity-score matching, in 2446 well-matched pairs, there was no significant difference in 30-day mortality (1.6% vs 1.8%, p=0.43) between MAG and SAG. Over a median and maximum follow-up of 5.0 and 11.0 years, respectively, MAG was associated with greater survival (HR 0.85, 95% CI 0.75 to 0.98) and freedom from MACCE (HR 0.85, 95% CI 0.76 to 0.95). MAG was associated with greater survival and freedom from MACCE and should be considered for women with good life expectancy requiring CA
Мне нравится
Комментарий
Перепост
